MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 89 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $127,710,000 | +5.1% | 10,750 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $121,475,000 | +4.4% | 10,750 | -18.9% | 0.01% | 0.0% |
| Q3 2014 | $116,335,000 | -12.8% | 13,250 | -27.6% | 0.01% | -10.0% |
| Q2 2014 | $133,407,000 | +34.8% | 18,300 | -6.8% | 0.01% | +25.0% |
| Q1 2014 | $98,996,000 | -26.7% | 19,642 | -22.5% | 0.01% | -27.3% |
| Q4 2013 | $135,098,000 | -27.0% | 25,342 | -48.1% | 0.01% | -31.2% |
| Q3 2013 | $185,119,000 | -43.8% | 48,844 | 0.0% | 0.02% | -46.7% |
| Q2 2013 | $329,208,000 | – | 48,844 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,211,880 | $17,474,000 | 4.63% |
| Parametrica Management Ltd | 21,228 | $168,000 | 1.11% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $653,000 | 0.73% |
| Virtus ETF Advisers LLC | 33,570 | $265,000 | 0.73% |
| Opus Point Partners Management, LLC | 122,500 | $968,000 | 0.64% |
| NEXTHERA CAPITAL LP | 36,000 | $284,000 | 0.40% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7,255,815 | $57,321,000 | 0.39% |
| Cannell & Co. | 1,051,178 | $7,751,000 | 0.25% |
| Tekla Capital Management LLC | 853,787 | $6,745,000 | 0.24% |
| STONERIDGE INVESTMENT PARTNERS LLC | 208,282 | $1,645,000 | 0.22% |